{"entity":{"type":"insider","cik":"0001701846","url":"/insider/0001701846","json_url":"/insider/0001701846.json","name":"Session R.A. II","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":4,"first":"2021-12-08","last":"2023-07-14","span_basis":"filed_date"},"name_variants":[{"name":"Session R.A. II","source":"filing","n_filings":4,"first_seen":"2021-12-08","last_seen":"2023-07-14"}],"transactions":[{"id":8695441,"accession":"0000950170-23-032986","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-032986","line_url":"/filing/0000950170-23-032986#line-2","is_derivative":false,"issuer_cik":"0001701846","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001701846","owner_cik":"0001701846","owner_name":"Session R.A. II","owner_display_name":"Session R.A. II","owner_url":"/insider/0001701846","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5344.0,"shares_display":"5,344","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":3740.8,"total_display":"3,740.80","total_whole":"3,741","shares_owned_after":8871747.0,"shares_owned_after_display":"8,871,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-13","filed_date":"2023-07-14","scope":"insider"},{"id":8695440,"accession":"0000950170-23-032986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-032986","line_url":"/filing/0000950170-23-032986#line-1","is_derivative":false,"issuer_cik":"0001701846","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001701846","owner_cik":"0001701846","owner_name":"Session R.A. II","owner_display_name":"Session R.A. II","owner_url":"/insider/0001701846","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80528.0,"shares_display":"80,528","price_per_share":0.7082,"price_display":"0.71","price_state":"stated","total_value":57029.9296,"total_display":"57,029.93","total_whole":"57,030","shares_owned_after":8877091.0,"shares_owned_after_display":"8,877,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-14","scope":"insider"},{"id":8010521,"accession":"0000899243-23-016491","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-016491","line_url":"/filing/0000899243-23-016491#line-2","is_derivative":false,"issuer_cik":"0001701846","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001701846","owner_cik":"0001701846","owner_name":"Session R.A. II","owner_display_name":"Session R.A. II","owner_url":"/insider/0001701846","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18100.0,"shares_display":"18,100","price_per_share":0.7036,"price_display":"0.70","price_state":"stated","total_value":12735.16,"total_display":"12,735.16","total_whole":"12,735","shares_owned_after":8957619.0,"shares_owned_after_display":"8,957,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-26","scope":"insider"},{"id":8010518,"accession":"0000899243-23-016491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-016491","line_url":"/filing/0000899243-23-016491#line-1","is_derivative":false,"issuer_cik":"0001701846","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001701846","owner_cik":"0001701846","owner_name":"Session R.A. II","owner_display_name":"Session R.A. II","owner_url":"/insider/0001701846","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10508.0,"shares_display":"10,508","price_per_share":0.7027,"price_display":"0.70","price_state":"stated","total_value":7383.9716,"total_display":"7,383.97","total_whole":"7,384","shares_owned_after":8975719.0,"shares_owned_after_display":"8,975,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-22","filed_date":"2023-06-26","scope":"insider"},{"id":8694557,"accession":"0000899243-23-016232","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-016232","line_url":"/filing/0000899243-23-016232#line-2","is_derivative":false,"issuer_cik":"0001701846","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001701846","owner_cik":"0001701846","owner_name":"Session R.A. II","owner_display_name":"Session R.A. II","owner_url":"/insider/0001701846","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138962.0,"shares_display":"138,962","price_per_share":0.7026,"price_display":"0.70","price_state":"stated","total_value":97634.7012,"total_display":"97,634.70","total_whole":"97,635","shares_owned_after":8986227.0,"shares_owned_after_display":"8,986,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-22","scope":"insider"},{"id":8694553,"accession":"0000899243-23-016232","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-016232","line_url":"/filing/0000899243-23-016232#line-1","is_derivative":false,"issuer_cik":"0001701846","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001701846","owner_cik":"0001701846","owner_name":"Session R.A. II","owner_display_name":"Session R.A. II","owner_url":"/insider/0001701846","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":295653.0,"shares_display":"295,653","price_per_share":0.711,"price_display":"0.71","price_state":"stated","total_value":210209.283,"total_display":"210,209.28","total_whole":"210,209","shares_owned_after":9125189.0,"shares_owned_after_display":"9,125,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":5114984,"accession":"0001209191-21-068510","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-068510","line_url":"/filing/0001209191-21-068510","is_derivative":false,"issuer_cik":"0001701846","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001701846","owner_cik":"0001701846","owner_name":"Session R.A. II","owner_display_name":"Session R.A. II","owner_url":"/insider/0001701846","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42518.0,"shares_display":"42,518","price_per_share":12.444197751540525,"price_display":"12.44","price_state":"stated","total_value":529102.4,"total_display":"529,102.40","total_whole":"529,102","shares_owned_after":9190920.0,"shares_owned_after_display":"9,190,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-12-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001806310","name":"Taysha Gene Therapies, Inc.","url":"/issuer/0001806310","role":"Director, Officer (President and CEO), Ten percent owner","n_filings":4,"first_seen":"2021-12-08","last_seen":"2023-07-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001701846","retrieved_at":"2026-08-27T02:36:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}